These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Phase I cancer trials: therapeutic research? Kodish E Hastings Cent Rep; 2001; 31(1):4-5. PubMed ID: 11478093 [No Abstract] [Full Text] [Related]
3. Phase I cancer trials. A collusion of misunderstanding. Miller M Hastings Cent Rep; 2000; 30(4):34-43. PubMed ID: 10971892 [No Abstract] [Full Text] [Related]
4. Statistical and ethical issues in the design and conduct of phase I and II clinical trials of new anticancer agents. Ratain MJ; Mick R; Schilsky RL; Siegler M J Natl Cancer Inst; 1993 Oct; 85(20):1637-43. PubMed ID: 8411243 [No Abstract] [Full Text] [Related]
5. Dying for a cure. Why cancer patients often turn to risky, experimental treatments--and wind up paying with their lives. Kaplan S; Brownlee S US News World Rep; 1999 Oct; 127(14):34-7, 40-3. PubMed ID: 10621514 [No Abstract] [Full Text] [Related]
6. Human subjects in weapons research. Caplan AL; Sankar P Science; 2002 Nov; 298(5595):923. PubMed ID: 12411671 [No Abstract] [Full Text] [Related]
7. An appraisal of human experimentation in international law and practice: the need for international regulation of human experimentation. Bassiouni MC; Baffes TG; Evrard JT J Crim Law Criminol; 1981; 72(4):1597-666. PubMed ID: 11649443 [No Abstract] [Full Text] [Related]
8. Subject selection for clinical trials. American Medical Association. Council on Ethical and Judicial Affairs IRB; 1998; 20(2-3):12-5. PubMed ID: 11656913 [No Abstract] [Full Text] [Related]
10. Modern medical research ethics. Tranøy KE Scand J Prim Health Care Suppl; 1993 Sep; 11(3):161-2. PubMed ID: 11654192 [No Abstract] [Full Text] [Related]
11. [Continual reassessment method (CRM)]. Ishizuka N Gan To Kagaku Ryoho; 2000 Aug; 27(9):1449-57. PubMed ID: 10969605 [TBL] [Abstract][Full Text] [Related]
12. Thinking clearly about research risk: implications of the work of Benjamin Freedman. Weijer C IRB; 1999; 21(6):1-5. PubMed ID: 11697392 [No Abstract] [Full Text] [Related]
13. Therapeutic misconception in early phase gene transfer trials. Henderson GE; Easter MM; Zimmer C; King NM; Davis AM; Rothschild BB; Churchill LR; Wilfond BS; Nelson DK Soc Sci Med; 2006 Jan; 62(1):239-53. PubMed ID: 16000230 [TBL] [Abstract][Full Text] [Related]
14. Phase I trials in cancer treatment. The maximum tolerated dose: a barbarian guideline. Degos L Hematol J; 2000; 1(4):219. PubMed ID: 11920193 [No Abstract] [Full Text] [Related]
15. The sex kitten of bioethics? Research ethics comes of age. Dresser R Hastings Cent Rep; 2008; 38(5):5. PubMed ID: 18947127 [No Abstract] [Full Text] [Related]
16. The ethics of phase I pediatric oncology trials. Ackerman TF IRB; 1995; 17(1):1-5. PubMed ID: 11653060 [No Abstract] [Full Text] [Related]
17. [Research. Patients in research studies are poorly informed]. Scocozza L Sygeplejersken; 1990 Jan; 90(3):8-14. PubMed ID: 2180098 [No Abstract] [Full Text] [Related]
18. Dying children and medical research: access to clinical trials as benefit and burden. Oberman M; Frader J Am J Law Med; 2003; 29(2-3):301-17. PubMed ID: 12961809 [No Abstract] [Full Text] [Related]
19. Ethics and errors of clinical trials and the role and place of different types of trial: introduction. Mathé G; Reizenstein P Drugs Exp Clin Res; 1986; 12(1-2-3):1-9. PubMed ID: 11650151 [No Abstract] [Full Text] [Related]
20. Referral and decision making among advanced cancer patients participating in Phase I trials at a single institution. Gordon EJ; Daugherty CK J Clin Ethics; 2001; 12(1):31-8. PubMed ID: 11428154 [No Abstract] [Full Text] [Related] [Next] [New Search]